BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Braicu C, Zimta AA, Harangus A, Iurca I, Irimie A, Coza O, Berindan-Neagoe I. The Function of Non-Coding RNAs in Lung Cancer Tumorigenesis. Cancers (Basel) 2019;11:E605. [PMID: 31052265 DOI: 10.3390/cancers11050605] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 15.3] [Reference Citation Analysis]
Number Citing Articles
1 Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, Rusu A, Irimie A, Atanasov AG, Slaby O, Ionescu C, Berindan-Neagoe I. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers (Basel) 2019;11:E1618. [PMID: 31652660 DOI: 10.3390/cancers11101618] [Cited by in Crossref: 134] [Cited by in F6Publishing: 125] [Article Influence: 44.7] [Reference Citation Analysis]
2 Pandey KK, Madhry D, Ravi Kumar YS, Malvankar S, Sapra L, Srivastava RK, Bhattacharyya S, Verma B. Regulatory roles of tRNA-derived RNA fragments in human pathophysiology. Mol Ther Nucleic Acids 2021;26:161-73. [PMID: 34513302 DOI: 10.1016/j.omtn.2021.06.023] [Reference Citation Analysis]
3 Iurca I, Tirpe A, Zimta AA, Moldovan C, Gulei D, Slabý O, Condorelli G, Berindan-Neagoe I. Macrophages Interaction and MicroRNA Interplay in the Modulation of Cancer Development and Metastasis. Front Immunol 2020;11:870. [PMID: 32477352 DOI: 10.3389/fimmu.2020.00870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zimta AA, Sigurjonsson OE, Gulei D, Tomuleasa C. The Malignant Role of Exosomes as Nanocarriers of Rare RNA Species. Int J Mol Sci 2020;21:E5866. [PMID: 32824183 DOI: 10.3390/ijms21165866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Du R, Jiang F, Yin Y, Xu J, Li X, Hu L, Wang X. Knockdown of lncRNA X inactive specific transcript (XIST) radiosensitizes non-small cell lung cancer (NSCLC) cells through regulation of miR-16-5p/WEE1 G2 checkpoint kinase (WEE1) axis. Int J Immunopathol Pharmacol 2021;35:2058738420966087. [PMID: 33583218 DOI: 10.1177/2058738420966087] [Reference Citation Analysis]
6 Guglas K, Kołodziejczak I, Kolenda T, Kopczyńska M, Teresiak A, Sobocińska J, Bliźniak R, Lamperska K. YRNAs and YRNA-Derived Fragments as New Players in Cancer Research and Their Potential Role in Diagnostics. Int J Mol Sci 2020;21:E5682. [PMID: 32784396 DOI: 10.3390/ijms21165682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Iacobas S, Ede N, Iacobas DA. The Gene Master Regulators (GMR) Approach Provides Legitimate Targets for Personalized, Time-Sensitive Cancer Gene Therapy. Genes (Basel). 2019;10. [PMID: 31349573 DOI: 10.3390/genes10080560] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
8 Song W, Ren J, Wang C, Ge Y, Fu T. Analysis of Circular RNA-Related Competing Endogenous RNA Identifies the Immune-Related Risk Signature for Colorectal Cancer. Front Genet 2020;11:505. [PMID: 32582276 DOI: 10.3389/fgene.2020.00505] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Catana CS, Crișan CA, Opre D, Berindan-Neagoe I. Implications of Long Non-Coding RNAs in Age-Altered Proteostasis. Aging Dis 2020;11:692-704. [PMID: 32489713 DOI: 10.14336/AD.2019.0814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zheng F, Xu R. CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis. Biomed Pharmacother 2020;124:109828. [PMID: 31986409 DOI: 10.1016/j.biopha.2020.109828] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
11 Rajagopal T, Talluri S, Venkatabalasubramanian S, Dunna NR. Multifaceted roles of long non-coding RNAs in triple-negative breast cancer: biology and clinical applications. Biochem Soc Trans 2020;48:2791-810. [PMID: 33258920 DOI: 10.1042/BST20200666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wang P, Zhou C, Li D, Zhang D, Wei L, Deng Y. circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-β/Smad and EGFR pathways. Oncol Lett 2021;22:563. [PMID: 34113391 DOI: 10.3892/ol.2021.12824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Qiu H, Zhang L, Yi T, Yang K, Gong Y, Xie C. Retracted: Long non-coding RNA TP73-AS1 facilitates progression and radioresistance in lung cancer cells by the miR-216a-5p/CUL4B axis with exosome involvement. Thorac Cancer 2021;12:409. [PMID: 32841514 DOI: 10.1111/1759-7714.13602] [Reference Citation Analysis]
14 Busuioc C, Ciocan-Cartita CA, Braicu C, Zanoaga O, Raduly L, Trif M, Muresan MS, Ionescu C, Stefan C, Crivii C, Al Hajjar N, Mǎrgǎrit S, Berindan-Neagoe I. Epithelial-Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma. J Pers Med 2021;11:476. [PMID: 34073426 DOI: 10.3390/jpm11060476] [Reference Citation Analysis]
15 Zhao WX, Tang YL, Wang WH, Bao MW. Up-regulation of circ_0000353 impedes the proliferation and metastasis of non-small cell lung cancer cells via adsorbing miR-411-5p and increasing forkhead box O1. Cancer Biomark 2020;29:25-37. [PMID: 32568175 DOI: 10.3233/CBM-190812] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Pirlog R, Cismaru A, Nutu A, Berindan-Neagoe I. Field Cancerization in NSCLC: A New Perspective on MicroRNAs in Macrophage Polarization. Int J Mol Sci 2021;22:E746. [PMID: 33451052 DOI: 10.3390/ijms22020746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Motzer RJ, Banchereau R, Hamidi H, Powles T, McDermott D, Atkins MB, Escudier B, Liu LF, Leng N, Abbas AR, Fan J, Koeppen H, Lin J, Carroll S, Hashimoto K, Mariathasan S, Green M, Tayama D, Hegde PS, Schiff C, Huseni MA, Rini B. Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade. Cancer Cell 2020;38:803-817.e4. [PMID: 33157048 DOI: 10.1016/j.ccell.2020.10.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 17.0] [Reference Citation Analysis]
18 Gan J, Li Y, Meng Q. Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer. Front Mol Biosci 2020;7:572406. [PMID: 33363204 DOI: 10.3389/fmolb.2020.572406] [Reference Citation Analysis]
19 Schitcu VH, Raduly L, Nutu A, Zanoaga O, Ciocan C, Munteanu VC, Cojocneanu R, Petrut B, Coman I, Braicu C, Berindan-neagoe I. MicroRNA Dysregulation in Prostate Cancer. PGPM 2022;Volume 15:177-93. [DOI: 10.2147/pgpm.s348565] [Reference Citation Analysis]
20 Dudea-Simon M, Mihu D, Irimie A, Cojocneanu R, Korban SS, Oprean R, Braicu C, Berindan-Neagoe I. Identification of Core Genes Involved in the Progression of Cervical Cancer Using an Integrative mRNA Analysis. Int J Mol Sci 2020;21:E7323. [PMID: 33023042 DOI: 10.3390/ijms21197323] [Reference Citation Analysis]
21 Xu K, Shi J, Mo D, Yang Y, Fu Q, Luo Y. miR-219a-1 inhibits colon cancer cells proliferation and invasion by targeting MEMO1. Cancer Biol Ther 2020;21:1163-70. [PMID: 33218285 DOI: 10.1080/15384047.2020.1843897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Drula R, Pirlog R, Trif M, Slaby O, Braicu C, Berindan-Neagoe I. circFOXO3: Going around the mechanistic networks in cancer by interfering with miRNAs regulatory networks. Biochim Biophys Acta Mol Basis Dis 2021;1867:166045. [PMID: 33513429 DOI: 10.1016/j.bbadis.2020.166045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zambalde EP, Adamoski D, Gradia DF, Rabinovich I, Rodrigues AC, Ivan C, Ribeiro EMSF, Calin GA, Carvalho de Oliveira J. Transcribed Ultraconserved Regions Are Associated with Clinicopathological Features in Breast Cancer. Biomolecules 2022;12:214. [DOI: 10.3390/biom12020214] [Reference Citation Analysis]
24 Wang YY, Duan H, Wang S, Quan YJ, Huang JH, Guo ZC. Elevated Circular RNA PVT1 Promotes Eutopic Endometrial Cell Proliferation and Invasion of Adenomyosis via miR-145/Talin1 Axis. Biomed Res Int 2021;2021:8868700. [PMID: 33728345 DOI: 10.1155/2021/8868700] [Reference Citation Analysis]
25 Drula R, Braicu C, Harangus A, Nabavi SM, Trif M, Slaby O, Ionescu C, Irimie A, Berindan-Neagoe I. Critical function of circular RNAs in lung cancer. Wiley Interdiscip Rev RNA 2020;11:e1592. [PMID: 32180372 DOI: 10.1002/wrna.1592] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
26 Gibert MK, Sarkar A, Chagari B, Roig-laboy C, Saha S, Bednarek S, Kefas B, Hanif F, Hudson K, Dube C, Zhang Y, Abounader R. Transcribed Ultraconserved Regions in Cancer. Cells 2022;11:1684. [DOI: 10.3390/cells11101684] [Reference Citation Analysis]
27 Yao J, Xue X, Qu D, Westphalen CB, Ge Y, Zhang L, Li M, Gao T, Chandrakesan P, Vega KJ, Peng J, An G, Weygant N. Reverse engineering a predictive signature characterized by proliferation, DNA damage, and immune escape from stage I lung adenocarcinoma recurrence. Acta Biochim Biophys Sin (Shanghai) 2020;52:638-53. [PMID: 32395755 DOI: 10.1093/abbs/gmaa036] [Reference Citation Analysis]
28 Haranguș A, Berindan-Neagoe I, Todea DA, Șimon I, Șimon M. Noncoding RNAs and Liquid Biopsy in Lung Cancer: A Literature Review. Diagnostics (Basel) 2019;9:E216. [PMID: 31818027 DOI: 10.3390/diagnostics9040216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Ling B, Liao X, Huang Y, Liang L, Jiang Y, Pang Y, Qi G. Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments. Int J Oncol 2020;56:193-205. [PMID: 31789390 DOI: 10.3892/ijo.2019.4926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
30 Alsaffar RM, Ali S, Rashid S, Rashid SM, Majid S, Rehman MU. Immunomodulation: An immune regulatory mechanism in carcinoma therapeutics. Int Immunopharmacol 2021;99:107984. [PMID: 34303999 DOI: 10.1016/j.intimp.2021.107984] [Reference Citation Analysis]
31 Li Y, Zhang J, Pan S, Zhou J, Diao X, Liu S. CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis. Thorac Cancer 2020;11:537-48. [PMID: 31917898 DOI: 10.1111/1759-7714.13274] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
32 Yu H, Tian L, Yang L, Liu S, Wang S, Gong J. Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC via Mediation of PI3K/Akt Signaling Pathway. Front Oncol 2021;11:620213. [PMID: 33816250 DOI: 10.3389/fonc.2021.620213] [Reference Citation Analysis]
33 Shi YX, Sheng DQ, Cheng L, Song XY. Current Landscape of Epigenetics in Lung Cancer: Focus on the Mechanism and Application. J Oncol 2019;2019:8107318. [PMID: 31889956 DOI: 10.1155/2019/8107318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
34 Yang X, Cao D, Ma W, Gao S, Wen G, Zhong J. Wnt signaling in triple-negative breast cancers: Its roles in molecular subtyping and cancer cell stemness and its crosstalk with non-coding RNAs. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120565] [Reference Citation Analysis]
35 Pan Q, Han T, Li G. Novel insights into the roles of tRNA-derived small RNAs. RNA Biol 2021;:1-11. [PMID: 33998370 DOI: 10.1080/15476286.2021.1922009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 He X, Xu T, Hu W, Tan Y, Wang D, Wang Y, Zhao C, Yi Y, Xiong M, Lv W, Wu M, Li X, Wu Y, Zhang Q. Circular RNAs: Their Role in the Pathogenesis and Orchestration of Breast Cancer. Front Cell Dev Biol 2021;9:647736. [PMID: 33777954 DOI: 10.3389/fcell.2021.647736] [Reference Citation Analysis]
37 Li D, Fu Z, Dong C, Song Y. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression. Bioengineered 2022;13:10493-503. [PMID: 35441574 DOI: 10.1080/21655979.2022.2061305] [Reference Citation Analysis]
38 Wang Y, Zhou D, Feng Y, Chen G, Li N. T-UCRs with digestive and respiratory diseases. Bioorg Med Chem Lett 2020;30:127306. [PMID: 32631526 DOI: 10.1016/j.bmcl.2020.127306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Braicu C, Zanoaga O, Zimta AA, Tigu AB, Kilpatrick KL, Bishayee A, Nabavi SM, Berindan-Neagoe I. Natural compounds modulate the crosstalk between apoptosis- and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells. Semin Cancer Biol 2020:S1044-579X(20)30111-5. [PMID: 32502598 DOI: 10.1016/j.semcancer.2020.05.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
40 Kubelac P, Braicu C, Raduly L, Chiroi P, Nutu A, Cojocneanu R, Budisan L, Berindan-Neagoe I, Achimas-Cadariu P. Comprehensive Analysis of the Expression of Key Genes Related to Hippo Signaling and Their Prognosis Impact in Ovarian Cancer. Diagnostics (Basel) 2021;11:344. [PMID: 33669647 DOI: 10.3390/diagnostics11020344] [Reference Citation Analysis]
41 Xie Y, Xue C, Guo S, Yang L. MicroRNA-520a Suppresses Pathogenesis and Progression of Non-Small-Cell Lung Cancer through Targeting the RRM2/Wnt Axis. Anal Cell Pathol (Amst) 2021;2021:9652420. [PMID: 33859925 DOI: 10.1155/2021/9652420] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Xu S, Jiang Y, Duan Y, Chatterjee S. hsa_circ_0077837 Alleviated the Malignancy of Non-Small Cell Lung Cancer by Regulating the miR-1178-3p/APITD1 Axis. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/3902832] [Reference Citation Analysis]
43 Chhatriya B, Mukherjee M, Ray S, Saha B, Lahiri S, Halder S, Ghosh I, Khamrui S, Das K, Bhattacharjee S, Mohapatra SK, Goswami S. Transcriptome analysis identifies putative multi-gene signature distinguishing benign and malignant pancreatic head mass. J Transl Med 2020;18:420. [PMID: 33160365 DOI: 10.1186/s12967-020-02597-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Janin M, Coll-SanMartin L, Esteller M. Disruption of the RNA modifications that target the ribosome translation machinery in human cancer. Mol Cancer 2020;19:70. [PMID: 32241281 DOI: 10.1186/s12943-020-01192-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
45 Krappinger JC, Bonstingl L, Pansy K, Sallinger K, Wreglesworth NI, Grinninger L, Deutsch A, El-Heliebi A, Kroneis T, Mcfarlane RJ, Sensen CW, Feichtinger J. Non-coding Natural Antisense Transcripts: Analysis and Application. J Biotechnol 2021:S0168-1656(21)00210-8. [PMID: 34371054 DOI: 10.1016/j.jbiotec.2021.08.005] [Reference Citation Analysis]
46 Guan H, Sun C, Gu Y, Li J, Ji J, Zhu Y. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer. Bioengineered 2021;12:2326-40. [PMID: 34077306 DOI: 10.1080/21655979.2021.1935064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Mei J, Hao L, Wang H, Xu R, Liu Y, Zhu Y, Liu C. Systematic characterization of non-coding RNAs in triple-negative breast cancer. Cell Prolif 2020;53:e12801. [PMID: 32249490 DOI: 10.1111/cpr.12801] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
48 Ishola AA, La'ah AS, Le HD, Nguyen VQ, Yang YP, Chou SJ, Tai HY, Chien CS, Wang ML. Non-coding RNA and lung cancer progression. J Chin Med Assoc 2020;83:8-14. [PMID: 31770191 DOI: 10.1097/JCMA.0000000000000225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
49 Xiao G, Wang P, Zheng X, Liu D, Sun X. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14. Cell Cycle 2019;18:2972-85. [PMID: 31522616 DOI: 10.1080/15384101.2019.1664225] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]